Efficacy News and Research

RSS
FDA clears TSO3's STERIZONE 125L Sterilizer for expanded use

FDA clears TSO3's STERIZONE 125L Sterilizer for expanded use

Controversy over recent breast cancer screening guidelines discussed

Controversy over recent breast cancer screening guidelines discussed

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

Neurologix completes Phase 2 clinical trial of Parkinson’s study

Neurologix completes Phase 2 clinical trial of Parkinson’s study

Osseon Therapeutics' Osseoflex and Osseoflex DR systems receive Canadian Medical Device Licenses

Osseon Therapeutics' Osseoflex and Osseoflex DR systems receive Canadian Medical Device Licenses

Pfizer announces a $9M cancer research collaboration in British Columbia

Pfizer announces a $9M cancer research collaboration in British Columbia

Two antimicrobial drug developing companies evaluate new approach for treating bacterial infections

Two antimicrobial drug developing companies evaluate new approach for treating bacterial infections

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

Report on the type 2 diabetes drug market in Brazil

Report on the type 2 diabetes drug market in Brazil

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

IsoRay to distribute Oncura's I-125 brachytherapy seed

IsoRay to distribute Oncura's I-125 brachytherapy seed

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Update on Celsion's ThermoDox Phase III “HEAT” trial for HCC

Update on Celsion's ThermoDox Phase III “HEAT” trial for HCC

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Nonanesthesiologist-administered propofol for GI procedures safe

Nonanesthesiologist-administered propofol for GI procedures safe

MaRS teams up with Baycrest to develop and market brain fitness products

MaRS teams up with Baycrest to develop and market brain fitness products

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

European Phase III clinical trial of budesonide MMX completes patient enrollment

European Phase III clinical trial of budesonide MMX completes patient enrollment

MIT scientists develop computer models to predict realistic drug delivery patterns from stents

MIT scientists develop computer models to predict realistic drug delivery patterns from stents

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.